NDC 71742-0001

Neuro-Pro T007

Gaba, L-dopa, Norepinephrine, Serotonin, Adrenocorticotrophin, Anacardium Orientale, Arsenicum Album, Baryta Carbonica, Calcarea Carbonica, Calcarea Phosphorica, Hyoscyamus Niger, Lycopodium Clavatum, Stramonium

Neuro-Pro T007 is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Guangzhou Renuma Medical Systems Co., Ltd. The primary component is .gamma.-aminobutyric Acid; Levodopa; Norepinephrine; Serotonin Hydrochloride; Corticotropin; Anacardium Occidentale Fruit; Arsenic Trioxide; Barium Carbonate; Oyster Shell Calcium Carbonate, Crude; Tribasic Calcium Phosphate; Hyoscyamus Niger; Lycopodium Clavatum Spore; Datura Stramonium.

Product ID71742-0001_33bf81ec-4693-464f-ab65-61cce5756124
NDC71742-0001
Product TypeHuman Otc Drug
Proprietary NameNeuro-Pro T007
Generic NameGaba, L-dopa, Norepinephrine, Serotonin, Adrenocorticotrophin, Anacardium Orientale, Arsenicum Album, Baryta Carbonica, Calcarea Carbonica, Calcarea Phosphorica, Hyoscyamus Niger, Lycopodium Clavatum, Stramonium
Dosage FormLiquid
Route of AdministrationORAL
Marketing Start Date2017-10-18
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameGuangzhou Renuma Medical Systems Co., Ltd
Substance Name.GAMMA.-AMINOBUTYRIC ACID; LEVODOPA; NOREPINEPHRINE; SEROTONIN HYDROCHLORIDE; CORTICOTROPIN; ANACARDIUM OCCIDENTALE FRUIT; ARSENIC TRIOXIDE; BARIUM CARBONATE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; TRIBASIC CALCIUM PHOSPHATE; HYOSCYAMUS NIGER; LYCOPODIUM CLAVATUM SPORE; DATURA STRAMONIUM
Active Ingredient Strength6 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 71742-0001-1

59 mL in 1 BOTTLE, DROPPER (71742-0001-1)
Marketing Start Date2017-10-18
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 71742-0001-1 [71742000101]

Neuro-Pro T007 LIQUID
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2017-10-18

Drug Details


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.